# Gilead’s IBD drug eliminated symptoms for patients, mid-stage study finds

> **Open Intelligence Dossier** · First detected: 2026-10-20 04:00 UTC · Category: Business

## Executive Summary
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Gilead’s IBD drug eliminated symptoms for patients, mid-stage study finds" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.


Outlets currently covering the story include AllSci, Reuters, Endpoints News and Fierce Biotech. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| AllSci | Gilead's oral α4β7 inhibitor meets Phase II ulcerative colitis endpoint, Phase III planned | [Source Link](https://news.google.com/rss/articles/CBMijwFBVV95cUxOMkVTYjJhMGZVcDNsR3h6bE5veEdocmRHUU9xdUdSQWNuU0NTN2J3U213aDdlMlFkbFptMG5zVW1wQll0TlhpeDRDVHA2M25yU3o3RmV2T2gxRnc5Nk5zMFhsQVdKSEd5MUJLRi12cFVzQV85Q0RTaHJ0bll2NVBXMFJJS3ZSeFlJVDJTYjFiYw?oc=5) |
| Reuters | Gilead's pill succeeds in mid-stage bowel disease trial | [Source Link](https://news.google.com/rss/articles/CBMiwAFBVV95cUxNTE5PbllEVXZrdUZkUFpwZGRHWFc0d2JnWWM1VGt5Q3YxdnJOVkw3YnBHQVNhYzgwVE1NVWNaSTZwcTlDTElEc05admVIRGcwWUpQcGFmWkdnWEczUmJDUTV2OUM1NURKUXBzQnluZXBiQnAwdTNRLVE2bTRadUF2RU1oRVJMRFhTdW5ZelBSQXUyaFAzWTlCOWxlQ1hfLVdjVkt6NkV2MkJkUng2eEN0RFAxMFVxSHZqR0ZzMGxielU?oc=5) |
| Endpoints News | Gilead’s pill posts stronger remission rates than Entyvio in ulcerative colitis | [Source Link](https://news.google.com/rss/articles/CBMikgFBVV95cUxPZkd5a2UzRjVlRm92MXVIRDRleVFlSFJuSUtFb0pZaGZTbHJ4LXRxbEFibWVxN3Z4MW1CTXN3TDA3dDdVMDlONHh3V0Zub3lQdk83YlRybTktSm5JbkhmZ2VMcjJLY3VRMms5NTRDRmRuZmhpNDFWd3FHNzNKbHhVWm9taVpOOGx3QWFjdFY4NGVPZw?oc=5) |
| Fierce Biotech | Gilead ‘sitting on a foundational asset’ after oral UC drug's phase 2 win | [Source Link](https://news.google.com/rss/articles/CBMirgFBVV95cUxNQk1pcThrdzdkZXd3d1RCOFZ1czZRdmc3TFU0STJ1bHNkUmZWZFZDcVJoTEdPRjRFVEhoVW43a3duNkxOMDdtMkUwbjhBSTQ1anZtR012TDRuTWJxNThQRi1WQ0xvTTJaeGV6Vzh3SzhCbFI0c3V6VnR0QklBNmx4b0RwWGI4SWtlVWlqQ1BMQkxBbXcza2Mtd0hzQ1AxMEpSVjNfa2s2WjlKcHpKUUE?oc=5) |
| STAT | Gilead’s IBD drug eliminated symptoms for patients, mid-stage study finds | [Source Link](https://news.google.com/rss/articles/CBMigAFBVV95cUxOUi1SV2dKUXl3LU9jNFpUSXZFZE9KbVBweHh6bXRzRGRMeEExcE5UOXVZaXd2NVBvQk45R3ZCZVU4Q3E5eEdTZFBMeElQYjJDT1hfU0s0RWFMaFM1alJNZnFXUUNPOGRldUtWNWpldjBKT0tvbXN0NDFzSXZzcVRVTg?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-10-20/gilead-s-ibd-drug-eliminated-symptoms-for-patients-mid-stage-study-finds*